title: Downregulation of tonic GABAergic inhibition in a mouse model of fragile X syndrome.
abstract: The absence of fragile X mental retardation protein results in the fragile X syndrome (FXS), a common form of mental retardation associated with attention deficit, autistic behavior, and epileptic seizures. The phenotype of FXS is reproduced in fragile X mental retardation 1 (fmr1) knockout (KO) mice that have region-specific altered expression of some gamma-aminobutyric acid (GABA(A)) receptor subunits. However, little is known about the characteristics of GABAergic inhibition in the subiculum of these animals. We employed patch-clamp recordings from subicular pyramidal cells in an in vitro slice preparation. In addition, semiquantitative polymerase chain reaction and western blot experiments were performed on subiculum obtained from wild-type (WT) and KO mice. We found that tonic GABA(A) currents were downregulated in fmr1 KO compared with WT neurons, whereas no significant differences were observed in phasic GABA(A) currents. Molecular biology analysis revealed that the tonic GABA(A) receptor subunits alpha5 and delta were underexpressed in the fmr1 KO mouse subiculum compared with WT. Because the subiculum plays a role in both cognitive functions and epileptic disorders, we propose that altered tonic inhibition in this structure contributes to the behavioral deficits and epileptic activity seen in FXS patients. This conclusion is in line with evidence implicating tonic GABA(A) inhibition in learning and memory.
authors.affiliation: Montreal Neurological Institute and Department of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada.
authors.forename: Giulia
authors.initials: G
authors.lastname: Curia
authors.forename: Thomas
authors.initials: T
authors.lastname: Papouin
authors.forename: Philippe
authors.initials: P
authors.lastname: Séguéla
authors.forename: Massimo
authors.initials: M
authors.lastname: Avoli
mesh_terms: D000818:Animals; D004195:Disease Models, Animal; D015536:Down-Regulation; D051860:Fragile X Messenger Ribonucleoprotein 1 / Q000235:genetics / Q000378:metabolism*; D005600:Fragile X Syndrome / Q000378:metabolism*; D006801:Humans; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D009433:Neural Inhibition; D011963:Receptors, GABA-A / Q000378:metabolism*; D009435:Synaptic Transmission; D005680:gamma-Aminobutyric Acid / Q000378:metabolism*
chemical_list: D051860:Fragile X Messenger Ribonucleoprotein 1; D011963:Receptors, GABA-A; D005680:gamma-Aminobutyric Acid; C497684:Fmr1 protein, mouse
references.citation: J Neurosci. 1994 Apr;14(4):2339-56
references.pmid: 8158272
references.citation: Proc Natl Acad Sci U S A. 2002 May 28;99(11):7746-50
references.pmid: 12032354
references.citation: Epilepsia. 2002;43 Suppl 5:3-8
references.pmid: 12121286
references.citation: Proc Natl Acad Sci U S A. 2005 Feb 8;102(6):2180-5
references.pmid: 15684045
references.citation: Proc Natl Acad Sci U S A. 2004 Mar 9;101(10):3662-7
references.pmid: 14993607
references.citation: Trends Genet. 2003 Mar;19(3):148-54
references.pmid: 12615009
references.citation: Neuron. 2003 Feb 20;37(4):555-8
references.pmid: 12597853
references.citation: Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):14374-8
references.pmid: 14614133
references.citation: Trends Neurosci. 2004 Jul;27(7):370-7
references.pmid: 15219735
references.citation: Epilepsia. 2005;46 Suppl 5:17-21
references.pmid: 15987248
references.citation: J Neurosci. 2005 Aug 10;25(32):7385-92
references.pmid: 16093389
references.citation: J Neurosci. 2008 Feb 6;28(6):1421-6
references.pmid: 18256262
references.citation: Neuroscience. 1997 Oct;80(4):987-1000
references.pmid: 9284055
references.citation: Neuron. 2003 Feb 6;37(3):417-31
references.pmid: 12575950
references.citation: J Neurosci. 1998 Oct 15;18(20):8505-14
references.pmid: 9763493
references.citation: Clin Genet. 2001 Dec;60(6):399-408
references.pmid: 11846731
references.citation: J Biol Chem. 1993 Mar 15;268(8):5965-73
references.pmid: 8383681
references.citation: Mol Cell Neurosci. 2002 Feb;19(2):138-51
references.pmid: 11860268
references.citation: Neurobiol Dis. 2006 Feb;21(2):346-57
references.pmid: 16199166
references.citation: Neuroimage. 2004 May;22(1):22-8
references.pmid: 15109994
references.citation: Gene. 2002 Jun 12;292(1-2):25-31
references.pmid: 12119096
references.citation: Science. 2002 Nov 15;298(5597):1418-21
references.pmid: 12434059
references.citation: J Comp Neurol. 1995 Aug 14;359(1):154-94
references.pmid: 8557845
references.citation: Biol Psychiatry. 2008 May 15;63(10):963-73
references.pmid: 18028882
references.citation: Neuroscience. 2003;119(1):9-13
references.pmid: 12763063
references.citation: Cytogenet Genome Res. 2003;100(1-4):111-23
references.pmid: 14526171
references.citation: J Neurophysiol. 2006 May;95(5):2796-807
references.pmid: 16452257
references.citation: Neuropharmacology. 2006 Nov;51(6):1023-9
references.pmid: 17046030
references.citation: J Neurosci. 2004 Sep 29;24(39):8629-39
references.pmid: 15456836
references.citation: J Neurosci. 2005 Oct 26;25(43):10016-24
references.pmid: 16251450
references.citation: Nucleic Acids Res. 2001 May 1;29(9):e45
references.pmid: 11328886
references.citation: J Physiol. 2005 Aug 1;566(Pt 3):885-900
references.pmid: 15932889
references.citation: Trends Neurosci. 2007 Aug;30(8):425-31
references.pmid: 17590448
references.citation: Cell. 1994 Jul 15;78(1):23-33
references.pmid: 8033209
references.citation: J Neurosci. 2007 Jul 11;27(28):7520-31
references.pmid: 17626213
references.citation: Neuroscience. 2005;134(2):691-704
references.pmid: 15951123
references.citation: Science. 1997 Apr 11;276(5310):264-6
references.pmid: 9092477
references.citation: J Neurosci. 2006 Aug 16;26(33):8600-8
references.pmid: 16914686
references.citation: Neurosci Lett. 2005 Apr 4;377(3):141-6
references.pmid: 15755515
references.citation: Biochem Biophys Res Commun. 2004 Jan 23;313(4):856-62
references.pmid: 14706621
references.citation: J Neurosci. 2004 Mar 17;24(11):2648-55
references.pmid: 15028757
references.citation: Neuropharmacology. 2005 Oct;49(5):573-86
references.pmid: 15950994
references.citation: Brain Res. 2006 Nov 22;1121(1):238-45
references.pmid: 17046729